Skip to Content

INCY 15 (Jakafi 15 mg)

Generic Name: ruxolitinib

This pill with imprint "INCY 15" is White, Elliptical / Oval and has been identified as Jakafi 15 mg. It is supplied by Incyte Corporation.

Jakafi is used in the treatment of myelofibrosis; polycythemia vera; myeloproliferative disorders and belongs to the drug class multikinase inhibitors. Risk cannot be ruled out during pregnancy. Jakafi 15 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for INCY 15

Jakafi

Generic Name:
ruxolitinib
Imprint:
INCY 15
Strength:
15 mg
Color:
White
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Multikinase inhibitors
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Incyte Corporation
Inactive Ingredients:
microcrystalline cellulose
lactose monohydrate
silicon dioxide
hydroxypropyl cellulose
povidone
sodium starch glycolate type A potato
magnesium stearate
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide